Home > Bulk & Specialty Chemicals > Biocatalyst Market

Biocatalyst Market Size, By Source (Animal, Plants, Microorganisms), By Type (Hydrolases, Oxidoreductases, Transferases), By Application (F&B Industry, Cleaning Agents, Biofuel Production, Agriculture & Feed, Biopharmaceuticals), Market Forecast, 2023 - 2032

  • Report ID: GMI5490
  • Published Date: Mar 2023
  • Report Format: PDF

Industry Statistics

Biocatalyst Market size attained a valuation of over USD 500 million in 2022 and is estimated to exhibit above 6% CAGR from 2023 to 2032 owing to the increasing demand for biocatalysts from the biopharmaceutical industry in manufacturing active pharmaceutical ingredients (API).

Biocatalyst Market

Get more details on this report - Request Free Sample PDF

The pharmaceutical sector has crossed leaps and bounds in recent years, given the escalating drug development projects and the growing prevalence of chronic and infectious diseases in people of all age groups.

Based on the Indian Economic Survey 2021, the pharmaceutical market in India stood at US$ 42 billion in 2021 and is predicted to register a three-fold growth by 2030, reaching US$ 120-130 billion by 2030. Since bio catalysis is extensively utilized across the pharmaceutical industry to catalyze chemical transformations to suffice the increasing requirements for a growing number of reactions during drug development. 

However, the lack of adequate regulations pertaining to the use of other competing technologies and applications may hamper market performance. In addition, limited consumer awareness about biocatalysts may challenge industry progression. In contrast, rising environmental concerns and the increasing penetration of biocatalysts across several industry verticals will favor market progress.

Hydrolases to witness increased growth due to their expansive application spectrum

Biocatalyst Market Size By Type

Get more details on this report - Request Free Sample PDF

Based on type, the overall market size is fragmented into Hydrolases, Oxidoreductases, Transferases, and Others comprising Lysase, Isomerases, and Ligases. The hydrolases segment of the biocatalyst market is slated to be worth USD 430 million by 2032, given the increasing usage of hydrolases in a range of cleansing agents, Food & Beverages, and biofuel production. Besides, the ease of use, broad range availability and high compatibility of hydrolases with organic solvents are some other factors fostering product adoption.

Escalating R&D projects to boost the demand for microbial-catalyzed bioenzymes

Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

Global market for biocatalyst was worth over USD 500 million in 2022 and is predicted to expand at more than 6% CAGR from 2023 to 2032, given the increasing utilization of biocatalysts in a variety of biopharmaceutical applications.

Microorganisms segment is estimated to grow at over 6% CAGR between 2023 and 2032, owing to growing R&D efforts toward the discovery of biologically active molecules with diversified structural features.

Hydrolases segment is poised to be valued at USD 430 million by 2032, attributed to the broad range availability, high compatibility of hydrolases with organic solvents, and increased ease of use associated with hydrolases.

Notable players in the biocatalyst market are BASF SE, Novozymes, DuPont, Codexis, Inc., Biocatalysts Limited, AB Enzymes, Prozomix Limited, Royal DSM, Lonza, Amano Enzyme Inc., Biosyntha Technology Ltd, and others.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 257
  • Countries covered: 19
  • Pages: 172
Inquiry Before Buying

Budget constraints? Get in touch with us for special pricing

Request Discount